An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel® in the US and Inovelon® in the EU.
Molecular Formula: C10H8F2N4O
Molecular Weight: 238.19
Linear Structural Formula: C10H8F2N4O
Storage: -20C
Application: An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older.
Legal Information: Snap-N-Spike is a registered trademark of Cerilliant Corporation